Proceedings of the National Academy of Sciences · 1996 · 186 citations · 26 references
MedicineMicrobiologyPathologyGastroenterologyInflammationMedical MicrobiologyGastrointestinal InfectionsGastrointestinal InflammationGastrointestinal PathologyInflammatory Bowel DiseaseInflammatory Disease PathologyMucosal InflammationColonic PathologyCrohn Disease PathologyDna Sequence AnalysisInflammatory Bowel Disease PathogenesisInflammatory Bowel Disease PathologyReverse Transcription Polymerase Chain Reaction (Rt-pcr)Tuberculoid LeprosyUlcerative Colitis Pathology
Crohn disease (CD) is a chronic, panenteric intestinal inflammatory disease. Its etiology is unknown. Analogous to the tuberculoid and lepromatous forms of leprosy, CD may have two clinical manifestations. One is aggressive and fistulizing (perforating), and the other is contained, indolent, and obstructive (nonperforating) [Gi]-berts, E. C. A. M., Greenstein, A. J., Katsel, P., Harpaz, N. & Greenstein, R. J. (1994) Proc. Natl. Acad. Sci. USA 91, 12721-127241. The etiology, if infections, may be due to Mycobacterium paratuberculosis. We employed reverse transcription PCR using M. paratuberculosis subspecies-specific primers (IS 900) on total RNA from 12 ileal mucosal specimens (CD, n = 8; controls, n = 4, 2 with ulcerative colitis and 2 with colonic cancer). As a negative control, we used Myobacterium avium DNA, originally cultured from the drinking water of a major city in the United States. cDNA sequence analysis shows that all eight cases of Crohn's disease and both samples from the patients with ulcerative colitis contained M. paratuberculosis RNA. Additionally, the M. avium control has the DNA sequence of M. paratuberculosis. We demonstrate the DNA sequence of M. paratuberculosis from mucosal specimens from humans with CD. The potable water supply may be a reservoir of infection. Although M. paratuberculosis signal in CD has been previously reported, a cause and effect relationship has not been established. In part, this is due to conflicting data from studies with empirical antimycobacterial therapy. We conclude that clinical trials with anti-M. paratuberculosis therapy are indicated in patients with CD who have been stratified into the aggressive (perforating) and contained (nonperforating) forms.
26
PATHOGENESIS OF CROHN'S DISEASE: MULTIFOCAL GASTROINTESTINAL INFARCTION
A J Wakefield, Amar P. Dhillon, P M Rowles et al. · The Lancet · 1989 · 587 citations
Medicine, Pathobiology, Pathology +14
Detection and identification of mycobacteria by amplification of rRNA
Boris Böddinghaus, T. Rogall, T Flohr et al. · Journal of Clinical Microbiology · 1990 · 519 citations · Full text
E.P. Green, Mark Tizard, M. Moss et al. · Nucleic Acids Research · 1989 · 463 citations · Full text
Defining protective responses to pathogens: cytokine profiles in leprosy lesions
Masayuki Yamamura, Koichi Uyemura, RJ Deans et al. · Science · 1991 · 392 citations